Scientific paper - Original scientific paper
TGF Beta as a Prognostic Biomarker of COVID-19 Severity in Patients with NAFLD: A Prospective Case – Control Study
Microorganisms, 11 (2023), 6; 1571. https://doi.org/10.3390/microorganisms11061571

Šušak, Frano; Vrsaljko, Nina; Vince, Adriana; Papić, Neven

Cite this document

Šušak, F., Vrsaljko, N., Vince, A. & Papić, N. (2023). TGF Beta as a Prognostic Biomarker of COVID-19 Severity in Patients with NAFLD: A Prospective Case – Control Study. Microorganisms, 11. (6). doi: 10.3390/microorganisms11061571

Šušak, Frano, et al. "TGF Beta as a Prognostic Biomarker of COVID-19 Severity in Patients with NAFLD: A Prospective Case – Control Study." Microorganisms, vol. 11, no. 6, 2023. https://doi.org/10.3390/microorganisms11061571

Šušak, Frano, Nina Vrsaljko, Adriana Vince and Neven Papić. "TGF Beta as a Prognostic Biomarker of COVID-19 Severity in Patients with NAFLD: A Prospective Case – Control Study." Microorganisms 11, no. 6 (2023). https://doi.org/10.3390/microorganisms11061571

Šušak, F., et al. (2023) 'TGF Beta as a Prognostic Biomarker of COVID-19 Severity in Patients with NAFLD: A Prospective Case – Control Study', Microorganisms, 11(6). doi: 10.3390/microorganisms11061571

Šušak F, Vrsaljko N, Vince A, Papić N. TGF Beta as a Prognostic Biomarker of COVID-19 Severity in Patients with NAFLD: A Prospective Case – Control Study. Microorganisms [Internet]. 2023 June 13 [cited 2024 October 14];11(6). doi: 10.3390/microorganisms11061571

F. Šušak, N. Vrsaljko, A. Vince and N. Papić, "TGF Beta as a Prognostic Biomarker of COVID-19 Severity in Patients with NAFLD: A Prospective Case – Control Study", Microorganisms, vol. 11, no. 6, June 2023. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:105:219307. [Accessed: 14 October 2024]

Please login to the repository to save this object to your list.